472 related articles for article (PubMed ID: 3019855)
1. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
3. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
4. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia.
Berkel AI; Henle W; Henle G; Klein G; Ersoy F; Sanal O
Clin Exp Immunol; 1979 Feb; 35(2):196-201. PubMed ID: 219976
[TBL] [Abstract][Full Text] [Related]
6. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
8. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
Seigneurin JM; Kressmann MC; Lavoué MF; Saez G; Lenoir G
Nouv Presse Med; 1978 Dec; 7(44):4005-10. PubMed ID: 215969
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infections in childhood.
Oberender H; Graessner U; Falkenhagen U; Kunkel M; Gärtner L; Kupatz H; Schumacher K
Acta Virol; 1979 Mar; 23(2):137-42. PubMed ID: 39436
[TBL] [Abstract][Full Text] [Related]
10. [Persistent Epstein-Barr virus infection].
Schneider H; Jobke A; Pernice W
Monatsschr Kinderheilkd; 1985 Dec; 133(12):897-900. PubMed ID: 3878942
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and cytomegalovirus antibodies in infectious mononucleosis.
Gergely L; Czeglédy J; Szalka A; Váczi L; Binder L
Acta Microbiol Acad Sci Hung; 1977; 24(1):13-9. PubMed ID: 201153
[TBL] [Abstract][Full Text] [Related]
12. The significance of serum IgM IgA and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis.
Hadar T; Margalith M; Sagiv E; Sarov B; Sarov I
Isr J Med Sci; 1995 May; 31(5):280-3. PubMed ID: 7759222
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
14. Serological follow-up of children with infectious mononucleosis caused by Epstein-Barr virus.
Timár L; Koller M; Budai J
Acta Paediatr Acad Sci Hung; 1981; 22(3):243-9. PubMed ID: 6272540
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
Czeglédy J; Gergely L; Váczi L; Szalka A
Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
[TBL] [Abstract][Full Text] [Related]
17. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.
Purtilo DT; Sakamoto K; Saemundsen AK; Sullivan JL; Synnerholm AC; Anvret M; Pritchard J; Sloper C; Sieff C; Pincott J; Pachman L; Rich K; Cruzi F; Cornet JA; Collins R; Barnes N; Knight J; Sandstedt B; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4226-36. PubMed ID: 6272967
[TBL] [Abstract][Full Text] [Related]
18. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
19. Contribution to rapid diagnosis of infectious mononucleosis.
Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
[TBL] [Abstract][Full Text] [Related]
20. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
Imai S
Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
